Apollo Hospitals Enterprise Ltd.

Apollo Hospitals Enterprise is currently trading at Rs 1358.10, up by 2.70 points or 0.20% from its previous closing of Rs. 1355.40 on the BSE.

The scrip opened at Rs. 1353.00 and has touched a high and low of Rs. 1360.00 and Rs. 1343.25 respectively. So far 4439 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1544.00 on 02-Mar-2016 and a 52 week low of Rs. 1131.80 on 30-Apr-2015.

Last one week high and low of the scrip stood at Rs. 1371.60 and Rs. 1325.00 respectively. The current market cap of the company is Rs. 18839.63 crore.

The promoters holding in the company stood at 34.35% while Institutions and Non-Institutions held 46.19% and 19.46% respectively.

In a bid to develop and promote precision oncology based on molecular and genetic analysis, Apollo Hospitals Enterprise has entered into partnership with molecular and genetic analysis company -- Datar Genetics.

The partnership will help the hospital use molecular and genetic analysis in diagnosis, treatment and monitoring of cancer. It will leverage technology to introduce precision matching for organ and bone marrow transplants. The companies will also participate in the research and development initiatives in cancer management and develop clinically implementable technologies.

Apollo Hospitals is the leading private sector healthcare provider in Asia and owns and manages a network of speciality hospitals and clinics, a chain of Pharmacy retail outlets across the country, and provides Consultancy Services for commissioning and managing the Speciality Hospitals.